Status:
COMPLETED
Therapeutic Lactose to Support Vaginal Microbiota
Lead Sponsor:
Peter Humaidan
Conditions:
Bacterial Vaginoses
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
The aim of the study was to investigate whether the administration of a vaginal tablet containing lactose can modulate the bacterial flora of women with bacterial vaginosis (BV). Design: Double-blind...
Eligibility Criteria
Inclusion
- Amsel criteria positive defined as 3/4 of the following: Vaginal discharge, Fishy odor, pH\>4.5 and Clue cells in a wet smear.
Exclusion
- Not able to provide written informed consent.
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03878511
Start Date
November 1 2012
End Date
March 1 2013
Last Update
March 19 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.